View More Recent Stories
-
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
-
Legend Biotech (LEGN) Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial
-
RBC Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
-
Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
-
Truist Securities Starts Legend Biotech Corp. (LEGN) at Buy
-
Top pharma stocks to own in 2024 – Citi

